Live Attenuated Vaccine Market Report

Global and China Live Attenuated Vaccine Industry Market Research Report (2017-2028)

  • POSTDATE：Nov 23, 2022
  • PAGES：135
  • REPORT CODE：GMM1399652
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Live Attenuated Vaccine industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • Merck & Co (US)

    • Johnson & Johnson (US)

    • Emergent BioSolutions (US)

    • Sanofi Pasteur (France)

    • Astellas Pharma (Japan)

    • GlaxoSmithKline (UK)

    • Serum Institute of India Pvt (India)

    • CSL Limited (Australia)

    • Pfizer (US)

    • MedImmune (US)

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • Pediatrics

    • Adults

    Application:

    • Hospital

    • Medical Center

    • Others

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 Live Attenuated Vaccine Industry Overview

      • 1.1.1 Live Attenuated Vaccine Market Scope and Market Segments

      • 1.1.2 Live Attenuated Vaccine Industry Characteristics

      • 1.1.3 Global and China Live Attenuated Vaccine Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China Live Attenuated Vaccine Production Value and Growth Rate (2017-2028)

    • 1.2 Global Live Attenuated Vaccine Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 Pediatrics

      • 1.2.2 Adults

    • 1.3 Global Live Attenuated Vaccine Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Hospital

      • 1.3.2 Medical Center

      • 1.3.3 Others

    • 1.4 Market Analysis by Region

      • 1.4.1 North America Live Attenuated Vaccine Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe Live Attenuated Vaccine Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC Live Attenuated Vaccine Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa Live Attenuated Vaccine Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global Live Attenuated Vaccine Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global Live Attenuated Vaccine Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China Live Attenuated Vaccine Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China Live Attenuated Vaccine Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global Live Attenuated Vaccine Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 Live Attenuated Vaccine Industry Porter's Five Forces Model Analysis

      • 2.2.3 Live Attenuated Vaccine Industry PEST Analysis

    • 2.3 Live Attenuated Vaccine Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 Live Attenuated Vaccine Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on Live Attenuated Vaccine Industry

    Chapter 3 Global and China Live Attenuated Vaccine Market, by Manufacturer

    • 3.1 Global and China Live Attenuated Vaccine Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China Live Attenuated Vaccine Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China Live Attenuated Vaccine Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China Live Attenuated Vaccine Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China Live Attenuated Vaccine Market Top 3 Players

    Chapter 4 Global and China Live Attenuated Vaccine Market, by Type (2017-2028)

    • 4.1 Live Attenuated Vaccine Market Trend, by Type

    • 4.2 Global Live Attenuated Vaccine Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global Live Attenuated Vaccine Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global Live Attenuated Vaccine Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global Live Attenuated Vaccine Price Trend, by Type (2017-2028)

    • 4.3 China Live Attenuated Vaccine Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China Live Attenuated Vaccine Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China Live Attenuated Vaccine Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China Live Attenuated Vaccine Price Trend, by Type (2017-2028)

    Chapter 5 Global and China Live Attenuated Vaccine Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global Live Attenuated Vaccine Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global Live Attenuated Vaccine Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global Live Attenuated Vaccine Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China Live Attenuated Vaccine Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China Live Attenuated Vaccine Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China Live Attenuated Vaccine Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global Live Attenuated Vaccine Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China Live Attenuated Vaccine Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America Live Attenuated Vaccine Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe Live Attenuated Vaccine Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC Live Attenuated Vaccine Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa Live Attenuated Vaccine Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America Live Attenuated Vaccine Market Analysis

    • 7.1 North America Live Attenuated Vaccine Market, by Type

    • 7.2 North America Live Attenuated Vaccine Market, by Application

    • 7.3 North America Live Attenuated Vaccine Market Analysis and Forecast, by Country

      • 7.3.1 United States Live Attenuated Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada Live Attenuated Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico Live Attenuated Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe Live Attenuated Vaccine Market Analysis

    • 8.1 Europe Live Attenuated Vaccine Market, by Type

    • 8.2 Europe Live Attenuated Vaccine Market, by Application

    • 8.3 Europe Live Attenuated Vaccine Market Analysis and Forecast, by Country

      • 8.3.1 Germany Live Attenuated Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK Live Attenuated Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France Live Attenuated Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy Live Attenuated Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries Live Attenuated Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain Live Attenuated Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium Live Attenuated Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland Live Attenuated Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia Live Attenuated Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey Live Attenuated Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC Live Attenuated Vaccine Market Analysis

    • 9.1 APAC Live Attenuated Vaccine Market, by Type

    • 9.2 APAC Live Attenuated Vaccine Market, by Application

    • 9.3 APAC Live Attenuated Vaccine Market Analysis and Forecast, by Country

      • 9.3.1 China Live Attenuated Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan Live Attenuated Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand Live Attenuated Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India Live Attenuated Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries Live Attenuated Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea Live Attenuated Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa Live Attenuated Vaccine Market Analysis

    • 10.1 Latin America, Middle East and Africa Live Attenuated Vaccine Market, by Type

    • 10.2 Latin America, Middle East and Africa Live Attenuated Vaccine Market, by Application

    • 10.3 Latin America, Middle East and Africa Live Attenuated Vaccine Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries Live Attenuated Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil Live Attenuated Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria Live Attenuated Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa Live Attenuated Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina Live Attenuated Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China Live Attenuated Vaccine Company Profiles

      • 11.1 Merck & Co (US)

        • 11.1.1 Merck & Co (US) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 Merck & Co (US) Live Attenuated Vaccine Product Profiles, Application and Specification

        • 11.1.3 Merck & Co (US) Live Attenuated Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 Johnson & Johnson (US)

        • 11.2.1 Johnson & Johnson (US) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 Johnson & Johnson (US) Live Attenuated Vaccine Product Profiles, Application and Specification

        • 11.2.3 Johnson & Johnson (US) Live Attenuated Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 Emergent BioSolutions (US)

        • 11.3.1 Emergent BioSolutions (US) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 Emergent BioSolutions (US) Live Attenuated Vaccine Product Profiles, Application and Specification

        • 11.3.3 Emergent BioSolutions (US) Live Attenuated Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 Sanofi Pasteur (France)

        • 11.4.1 Sanofi Pasteur (France) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 Sanofi Pasteur (France) Live Attenuated Vaccine Product Profiles, Application and Specification

        • 11.4.3 Sanofi Pasteur (France) Live Attenuated Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 Astellas Pharma (Japan)

        • 11.5.1 Astellas Pharma (Japan) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 Astellas Pharma (Japan) Live Attenuated Vaccine Product Profiles, Application and Specification

        • 11.5.3 Astellas Pharma (Japan) Live Attenuated Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 GlaxoSmithKline (UK)

        • 11.6.1 GlaxoSmithKline (UK) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 GlaxoSmithKline (UK) Live Attenuated Vaccine Product Profiles, Application and Specification

        • 11.6.3 GlaxoSmithKline (UK) Live Attenuated Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.7 Serum Institute of India Pvt (India)

        • 11.7.1 Serum Institute of India Pvt (India) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.7.2 Serum Institute of India Pvt (India) Live Attenuated Vaccine Product Profiles, Application and Specification

        • 11.7.3 Serum Institute of India Pvt (India) Live Attenuated Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.8 CSL Limited (Australia)

        • 11.8.1 CSL Limited (Australia) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.8.2 CSL Limited (Australia) Live Attenuated Vaccine Product Profiles, Application and Specification

        • 11.8.3 CSL Limited (Australia) Live Attenuated Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.9 Pfizer (US)

        • 11.9.1 Pfizer (US) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.9.2 Pfizer (US) Live Attenuated Vaccine Product Profiles, Application and Specification

        • 11.9.3 Pfizer (US) Live Attenuated Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.10 MedImmune (US)

        • 11.10.1 MedImmune (US) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.10.2 MedImmune (US) Live Attenuated Vaccine Product Profiles, Application and Specification

        • 11.10.3 MedImmune (US) Live Attenuated Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 Live Attenuated Vaccine Industry Investment Prospect and Risk Assessment

    • 12.1 Live Attenuated Vaccine Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 Live Attenuated Vaccine Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global Live Attenuated Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure China Live Attenuated Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Global Live Attenuated Vaccine Production Value and Growth Rate (2017-2028)

    • Figure China Live Attenuated Vaccine Production Value and Growth Rate (2017-2028)

    • Figure Global Live Attenuated Vaccine Market Size and Growth Rate of Pediatrics (2017-2028)

    • Figure Global Live Attenuated Vaccine Market Size and Growth Rate of Adults (2017-2028)

    • Figure Global Live Attenuated Vaccine Market Size and Growth Rate of Hospital (2017-2028)

    • Figure Global Live Attenuated Vaccine Market Size and Growth Rate of Medical Center (2017-2028)

    • Figure Global Live Attenuated Vaccine Market Size and Growth Rate of Others (2017-2028)

    • Figure North America Live Attenuated Vaccine Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe Live Attenuated Vaccine Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC Live Attenuated Vaccine Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa Live Attenuated Vaccine Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global Live Attenuated Vaccine Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China Live Attenuated Vaccine Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China Live Attenuated Vaccine Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China Live Attenuated Vaccine Sales Value, by Manufacturer (2021&2022)

    • Table Global and China Live Attenuated Vaccine Market Share, by Manufacturer (2021&2022)

    • Figure Global and China Live Attenuated Vaccine Market Share, by Manufacturer in 2021

    • Figure Global and China Live Attenuated Vaccine Market Share, by Manufacturer in 2022

    • Table Global Live Attenuated Vaccine Sales Volume, by Type (2017-2028)

    • Table Global Live Attenuated Vaccine Sales Volume Share, by Type (2017-2028)

    • Figure Global Live Attenuated Vaccine Sales Volume Share, by Type (2017-2028)

    • Table Global Live Attenuated Vaccine Sales Value, by Type (2017-2028)

    • Table Global Live Attenuated Vaccine Sales Value Share, by Type (2017-2028)

    • Figure Global Live Attenuated Vaccine Price Trend, by Type (2017-2028)

    • Table China Live Attenuated Vaccine Sales Volume, by Type (2017-2028)

    • Table China Live Attenuated Vaccine Sales Volume Share, by Type (2017-2028)

    • Figure China Live Attenuated Vaccine Sales Volume Share, by Type (2017-2028)

    • Table China Live Attenuated Vaccine Sales Value, by Type (2017-2028)

    • Table China Live Attenuated Vaccine Sales Value Share, by Type (2017-2028)

    • Figure China Live Attenuated Vaccine Price Trend, by Type (2017-2028)

    • Table Global Live Attenuated Vaccine Sales Volume, by Application (2017-2028)

    • Table Global Live Attenuated Vaccine Sales Volume Share, by Application (2017-2028)

    • Figure Global Live Attenuated Vaccine Sales Volume Share, by Application (2017-2028)

    • Table Global Live Attenuated Vaccine Sales Value, by Application (2017-2028)

    • Table Global Live Attenuated Vaccine Sales Value Share, by Application (2017-2028)

    • Figure Global Live Attenuated Vaccine Sales Value Share, by Application (2017-2028)

    • Table China Live Attenuated Vaccine Sales Volume, by Application (2017-2028)

    • Table China Live Attenuated Vaccine Sales Volume Share, by Application (2017-2028)

    • Figure China Live Attenuated Vaccine Sales Volume Share, by Application (2017-2028)

    • Table China Live Attenuated Vaccine Sales Value, by Application (2017-2028)

    • Table China Live Attenuated Vaccine Sales Value Share, by Application (2017-2028)

    • Figure China Live Attenuated Vaccine Sales Value Share, by Application (2017-2028)

    • Figure China Live Attenuated Vaccine Production, Import, Consumption and Export (2017-2022)

    • Figure North America Live Attenuated Vaccine Production, Import, Consumption and Export (2017-2022)

    • Figure Europe Live Attenuated Vaccine Production, Import, Consumption and Export (2017-2022)

    • Figure APAC Live Attenuated Vaccine Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa Live Attenuated Vaccine Production, Import, Consumption and Export (2017-2022)

    • Table North America Live Attenuated Vaccine Sales Volume, by Type (2017-2028)

    • Table North America Live Attenuated Vaccine Sales Volume Share, by Type (2017-2028)

    • Figure North America Live Attenuated Vaccine Sales Volume Share, by Type (2017-2028)

    • Table North America Live Attenuated Vaccine Sales Volume, by Application (2017-2028)

    • Table North America Live Attenuated Vaccine Sales Volume Share, by Application (2017-2028)

    • Figure North America Live Attenuated Vaccine Sales Volume Share, by Application (2017-2028)

    • Figure United States Live Attenuated Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure United States Live Attenuated Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Canada Live Attenuated Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Canada Live Attenuated Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Mexico Live Attenuated Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico Live Attenuated Vaccine Sales Value and Growth Rate (2017-2028)

    • Table Europe Live Attenuated Vaccine Sales Volume, by Type (2017-2028)

    • Table Europe Live Attenuated Vaccine Sales Volume Share, by Type (2017-2028)

    • Figure Europe Live Attenuated Vaccine Sales Volume Share, by Type (2017-2028)

    • Table Europe Live Attenuated Vaccine Sales Volume, by Application (2017-2028)

    • Table Europe Live Attenuated Vaccine Sales Volume Share, by Application (2017-2028)

    • Figure Europe Live Attenuated Vaccine Sales Volume Share, by Application (2017-2028)

    • Figure Germany Live Attenuated Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Germany Live Attenuated Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure UK Live Attenuated Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure UK Live Attenuated Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure France Live Attenuated Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure France Live Attenuated Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Italy Live Attenuated Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Italy Live Attenuated Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries Live Attenuated Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries Live Attenuated Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Spain Live Attenuated Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Spain Live Attenuated Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Belgium Live Attenuated Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium Live Attenuated Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Poland Live Attenuated Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Poland Live Attenuated Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Russia Live Attenuated Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Russia Live Attenuated Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Turkey Live Attenuated Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey Live Attenuated Vaccine Sales Value and Growth Rate (2017-2028)

    • Table APAC Live Attenuated Vaccine Sales Volume, by Type (2017-2028)

    • Table APAC Live Attenuated Vaccine Sales Volume Share, by Type (2017-2028)

    • Figure APAC Live Attenuated Vaccine Sales Volume Share, by Type (2017-2028)

    • Table APAC Live Attenuated Vaccine Sales Volume, by Application (2017-2028)

    • Table APAC Live Attenuated Vaccine Sales Volume Share, by Application (2017-2028)

    • Figure APAC Live Attenuated Vaccine Sales Volume Share, by Application (2017-2028)

    • Figure China Live Attenuated Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure China Live Attenuated Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Japan Live Attenuated Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Japan Live Attenuated Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Live Attenuated Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Live Attenuated Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure India Live Attenuated Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure India Live Attenuated Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries Live Attenuated Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries Live Attenuated Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure South Korea Live Attenuated Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea Live Attenuated Vaccine Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa Live Attenuated Vaccine Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Live Attenuated Vaccine Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa Live Attenuated Vaccine Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Live Attenuated Vaccine Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa Live Attenuated Vaccine Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa Live Attenuated Vaccine Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries Live Attenuated Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries Live Attenuated Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Brazil Live Attenuated Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil Live Attenuated Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria Live Attenuated Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria Live Attenuated Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure South Africa Live Attenuated Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa Live Attenuated Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Argentina Live Attenuated Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina Live Attenuated Vaccine Sales Value and Growth Rate (2017-2028)

    • Table Merck & Co (US) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Merck & Co (US) Product Profiles, Application and Specification

    • Table Merck & Co (US) Live Attenuated Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Johnson & Johnson (US) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Johnson & Johnson (US) Product Profiles, Application and Specification

    • Table Johnson & Johnson (US) Live Attenuated Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Emergent BioSolutions (US) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Emergent BioSolutions (US) Product Profiles, Application and Specification

    • Table Emergent BioSolutions (US) Live Attenuated Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Sanofi Pasteur (France) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Sanofi Pasteur (France) Product Profiles, Application and Specification

    • Table Sanofi Pasteur (France) Live Attenuated Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Astellas Pharma (Japan) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Astellas Pharma (Japan) Product Profiles, Application and Specification

    • Table Astellas Pharma (Japan) Live Attenuated Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table GlaxoSmithKline (UK) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table GlaxoSmithKline (UK) Product Profiles, Application and Specification

    • Table GlaxoSmithKline (UK) Live Attenuated Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Serum Institute of India Pvt (India) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Serum Institute of India Pvt (India) Product Profiles, Application and Specification

    • Table Serum Institute of India Pvt (India) Live Attenuated Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table CSL Limited (Australia) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table CSL Limited (Australia) Product Profiles, Application and Specification

    • Table CSL Limited (Australia) Live Attenuated Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Pfizer (US) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Pfizer (US) Product Profiles, Application and Specification

    • Table Pfizer (US) Live Attenuated Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table MedImmune (US) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table MedImmune (US) Product Profiles, Application and Specification

    • Table MedImmune (US) Live Attenuated Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US